Table 2.
Descriptive features of the sample with mood instability-only, sleep disturbance-only, mood instability and sleep disturbance, and no mood instability or sleep disturbance within 1 month of presenting to OHFT (n = 31,391).
| Mood instability-only | Sleep disturbance-only | Mood instability and sleep disturbance | No mood instability or sleep disturbance | |||||
|---|---|---|---|---|---|---|---|---|
| (n = 1,322) | (n = 6,559) | (n = 1,684) | (n = 21,826) | |||||
| n | % | n | % | n | % | n | % | |
| Age | ||||||||
| 16–25 | 164 | 12.41 | 567 | 8.64 | 176 | 10.45 | 2,122 | 9.72 |
| 26–35 | 426 | 32.22 | 1,966 | 29.97 | 578 | 34.32 | 6,629 | 30.37 |
| 36–45 | 360 | 27.23 | 1,907 | 29.07 | 473 | 28.09 | 5,936 | 27.20 |
| 46–55 | 315 | 23.83 | 1,703 | 25.96 | 360 | 21.38 | 4,707 | 21.57 |
| 56–65 | 57 | 4.31 | 416 | 6.34 | 97 | 5.76 | 2,432 | 11.14 |
| Gender, female | 761 | 57.56 | 3,408 | 51.96 | 939 | 55.76 | 12,096 | 55.42 |
| Diagnosis | ||||||||
| Any | 231 | 17.47 | 1,460 | 22.26 | 503 | 29.87 | 2,560 | 11.73 |
| Organic | <5 | – | 11 | 0.17 | <5 | – | 71 | 0.33 |
| Substance use | 24 | 1.82 | 143 | 2.18 | 53 | 3.15 | 166 | 0.76 |
| Schizophrenia and related | 29 | 2.19 | 208 | 3.17 | 58 | 3.44 | 470 | 2.15 |
| Mood | 90 | 6.81 | 719 | 10.96 | 274 | 16.27 | 919 | 4.21 |
| Anxiety | 48 | 3.63 | 361 | 5.5 | 88 | 5.23 | 484 | 2.22 |
| Behavioral syndrome | 25 | 1.89 | 83 | 1.27 | 19 | 1.13 | 346 | 1.59 |
| Personality | 37 | 2.80 | 120 | 1.83 | 78 | 4.63 | 254 | 1.16 |
| Mental retardation | <5 | – | <5 | – | <5 | – | <5 | – |
| Developmental | <5 | – | 5 | 0.08 | <5 | – | 32 | 0.15 |
| Behavioral/emotional | <5 | – | 9 | 0.14 | <5 | – | 43 | 0.20 |
| Unspecified | <5 | – | 22 | 0.34 | 12 | 0.71 | 61 | 0.28 |
| Medication | ||||||||
| 1 | 283 | 21.41 | 1,241 | 18.92 | 268 | 15.91 | 1,990 | 9.12 |
| 2 | 208 | 15.73 | 1,063 | 16.21 | 243 | 14.43 | 1,171 | 5.37 |
| 3+ | 232 | 17.55 | 1,944 | 29.64 | 836 | 49.64 | 1,038 | 4.76 |
| Any | 723 | 54.77 | 4,248 | 64.77 | 1,347 | 79.99 | 4,199 | 19.24 |
| Antidepressant | 475 | 35.93 | 3,158 | 48.15 | 901 | 53.50 | 2,973 | 13.62 |
| Antipsychotic | 255 | 19.29 | 1,529 | 23.31 | 642 | 38.12 | 1,395 | 6.39 |
| Mood-stabilizing antiepileptic | 62 | 4.69 | 181 | 2.76 | 114 | 6.77 | 225 | 1.03 |
| Sedative hypnotic | 183 | 13.84 | 1,597 | 24.35 | 673 | 39.96 | 912 | 4.18 |
| Lithium | 26 | 1.97 | 86 | 1.31 | 57 | 3.38 | 115 | 0.53 |
| Sedating antihistamine | 6 | 0.45 | 57 | 0.87 | 32 | 1.90 | 20 | 0.09 |
| Sympathomimetic | <5 | – | 21 | 0.32 | 7 | 0.42 | 42 | 0.19 |
| Amphetamine | <5 | – | <5 | – | <5 | – | 6 | 0.03 |
| Events | ||||||||
| 12–23 | 117 | 8.85 | 493 | 7.52 | 59 | 3.50 | 4,694 | 21.51 |
| 24–35 | 159 | 12.03 | 658 | 10.03 | 99 | 5.88 | 4,466 | 20.46 |
| 36+ | 1,002 | 75.79 | 5,200 | 79.28 | 1,449 | 86.04 | 11,777 | 53.87 |
| Hospitalization | ||||||||
| Days in hospital, mean (SD) | 89 | 17.40 (11.04) | 580 | 14.73 (10.72) | 429 | 16.92 (10.15) | 374 | 16.43 (11.67) |
| 1 | 88 | 6.66 | 560 | 8.54 | 408 | 24.23 | 363 | 1.66 |
| 2 | <5 | – | 20 | 0.30 | 20 | 1.19 | 11 | 0.05 |
| 3+ | <5 | – | <5 | – | <5 | – | <5 | – |
| HoNOS, mean (SD) | 69 | 10.45 (5.16) | 377 | 11.94 (6.67) | 114 | 12.12 (6.10) | 427 | 11.02 (5.87) |
Abbreviation: HoNOS, Health of the Nation Outcome Scale adjusted total score.
– represents estimates unavailable due to small numbers.